Unknown

Dataset Information

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure.


ABSTRACT:

Background

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Metabolomics may help refine risk assessment and potentially guide HF management, but dedicated studies are few. This study aims at stratifying the long-term risk of death in a cohort of patients affected by HF due to dilated cardiomyopathy (DCM) using serum metabolomics via nuclear magnetic resonance (NMR) spectroscopy.

Methods

A cohort of 106 patients with HF due to DCM, diagnosed and monitored between 1982 and 2011, were consecutively enrolled between 2010 and 2012, and a serum sample was collected from each participant. Each patient underwent half-yearly clinical assessments, and survival status at the last follow-up visit in 2019 was recorded. The NMR serum metabolomic profiles

SUBMITTER: Vignoli A 

PROVIDER: S-EPMC9021397 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature